Home
News
In Focus
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Restaurants get off to a quick start thanks to game-changing policies
High service charges on event ticket refunds call for further regulation
Sunday
- Subscribe
Related News
Market seen to continue climb
By Ding Yining |
June 22, 2009, Monday
|
Print Edition
Print Edition
SHANGHAI'S key stock index is likely to fluctuate this week after it gained for five days last week, but brokerages are confident that the market will keep its upward movement.
The Shanghai Composite Index added a combined 4.84 percent, or 132.93 points, last week to end at 2,880.49 points on Friday.
"The market has been strong in the past few (trading) days and some of the investors may take profit before there are clear signs of economic recovery," China Merchant Securities wrote in a research report.
"Initial public offerings will have limited effect on investors and we think property developers, financial shares and coal producers may outperform the market," wrote the report.
Guilin Sanjin Pharmaceutical Co aims to raise 600 million yuan (US$87.7 million) by selling 46 million A-shares when it becomes the first company to launch an IPO after a nine-month hiatus.
"Despite fluctuation in the short term, the market will maintain its upward trend in the second half of the year," a CITIC Securities research report said.
"There will be less deflation risk in the third quarter and some of the heavyweights are undervalued at the moment, which offer investment opportunities," the report said.
The Shanghai Composite Index added a combined 4.84 percent, or 132.93 points, last week to end at 2,880.49 points on Friday.
"The market has been strong in the past few (trading) days and some of the investors may take profit before there are clear signs of economic recovery," China Merchant Securities wrote in a research report.
"Initial public offerings will have limited effect on investors and we think property developers, financial shares and coal producers may outperform the market," wrote the report.
Guilin Sanjin Pharmaceutical Co aims to raise 600 million yuan (US$87.7 million) by selling 46 million A-shares when it becomes the first company to launch an IPO after a nine-month hiatus.
"Despite fluctuation in the short term, the market will maintain its upward trend in the second half of the year," a CITIC Securities research report said.
"There will be less deflation risk in the third quarter and some of the heavyweights are undervalued at the moment, which offer investment opportunities," the report said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
